TTY Biopharm Company Limited announced its generic drug - Arsenic Trioxide has been approved by US FDA. TTY Biopharm and global partner jointly developed generic drug - Arsenic Trioxide for US and Europe market. The indication is for acute myeloid leukemia and has been approved by US FDA. TTY Biopharm develops this generic drug and global partner is responsible for registeration and sales for overseas markets. TTY Biopharm would receive milestone payment according to agreement with profit from prduct supply after launch.